clinical trials for glp-1 obesity meds actively recruiting Pharmacology Consult: receptor agonists weight loss management GLP-1 Receptor Agonists for Weight

Beyond their well-known metabolic and cardiovascular benefits, we explore: Gastrointestinal adverse effects Gallbladder and biliary complications Eye complications Renal safety Lean mass loss during weight reduction Suicidal ideation signals Real-world treatment discontinuation patterns This work bridges insights from clinical trials, real-world data, and regulatory pharmacovigilance reports to help clinicians navigate the nuanced safety landscape of GLP-1RA therapy in diverse patient populations

This is usually followed by a break of equal or longer length to give receptors a chance to reset

Secondary outcomes included endoscopy use and prescriptions for gastrointestinal medications such as laxatives and prokinetics

eLife 5 , e17219 (2016) Adams, P